title: Specific vaccine therapy in chronic hepatitis B infection.
authors.forename: S
authors.initials: S
authors.lastname: Pol
authors.forename: F
authors.initials: F
authors.lastname: Driss
authors.forename: M L
authors.initials: ML
authors.lastname: Michel
authors.forename: B
authors.initials: B
authors.lastname: Nalpas
authors.forename: P
authors.initials: P
authors.lastname: Berthelot
authors.forename: C
authors.initials: C
authors.lastname: Brechot
mesh_terms: D000328:Adult; D002908:Chronic Disease; D004279:DNA, Viral / Q000097:blood; D005260:Female; D006509:Hepatitis B / Q000382:microbiology / Q000628:therapy*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006515:Hepatitis B virus / Q000302:isolation & purification; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D008297:Male; D010865:Pilot Projects; D011994:Recombinant Proteins; D014611:Vaccination
chemical_list: D004279:DNA, Viral; C075656:GenHevac B Pasteur; D017325:Hepatitis B Vaccines; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins